GW Pharmaceuticals plc Company Profile (LON:GWP)

About GW Pharmaceuticals plc (LON:GWP)

GW Pharmaceuticals plc logoGW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: LON:GWP
  • CUSIP: N/A
  • Web: https://www.gwpharm.com/
Average Prices:
  • 50 Day Moving Avg: GBX 810.64
  • 200 Day Moving Avg: GBX 650.91
  • 52 Week Range: GBX 211 - GBX 950
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Profitability:
  • Net Margins: -1,673.22%
  • Return on Equity: -48.31%
  • Return on Assets: -42.39%
Misc:
  • Average Volume: 811,003 shs.
 

Frequently Asked Questions for GW Pharmaceuticals plc (LON:GWP)

What is GW Pharmaceuticals plc's stock symbol?

GW Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "GWP."

Where is GW Pharmaceuticals plc's stock going? Where will GW Pharmaceuticals plc's stock price be in 2017?

1 brokerages have issued 12 month target prices for GW Pharmaceuticals plc's shares. Their forecasts range from GBX 835 to GBX 835. On average, they anticipate GW Pharmaceuticals plc's stock price to reach GBX 835 in the next twelve months. View Analyst Ratings for GW Pharmaceuticals plc.

Who are some of GW Pharmaceuticals plc's key competitors?

Who are GW Pharmaceuticals plc's key executives?

GW Pharmaceuticals plc's management team includes the folowing people:

  • Geoffrey W. Guy, Executive Chairman of the Board
  • Justin Gover, Chief Executive Officer, Director
  • Adam David George, Chief Financial Officer, Company Secretary, Director
  • Christopher John Tovey, Chief Operating Officer, Executive Director
  • Julian S. Gangolli, Executive Director
  • James Julian Noble, Non-Executive Deputy Chairman of the Board, Senior Independent Director
  • Cabot Brown, Non-Executive Independent Director
  • Thomas Gerard Lynch, Non-Executive Independent Director

How do I buy GW Pharmaceuticals plc stock?

Shares of GW Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GW Pharmaceuticals plc's stock price today?

One share of GW Pharmaceuticals plc stock can currently be purchased for approximately GBX 716.60.


MarketBeat Community Rating for GW Pharmaceuticals plc (LON GWP)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about GW Pharmaceuticals plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for GW Pharmaceuticals plc (LON:GWP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: GBX 835

Analysts' Ratings History for GW Pharmaceuticals plc (LON:GWP)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016Numis Securities LtdReiterated RatingHoldGBX 835View Rating Details
3/14/2016Peel HuntReiterated RatingUnder ReviewView Rating Details
(Data available from 9/21/2015 forward)

Earnings

Earnings History for GW Pharmaceuticals plc (LON:GWP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for GW Pharmaceuticals plc (LON:GWP)
Current Year EPS Consensus Estimate: $-31.300 EPS

Dividends

Dividend History for GW Pharmaceuticals plc (LON:GWP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for GW Pharmaceuticals plc (LON:GWP)
Insider Trades by Quarter for GW Pharmaceuticals plc (LON:GWP)
Insider Trades by Quarter for GW Pharmaceuticals plc (LON:GWP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2016Tom LynchInsiderSell2,074GBX 790£16,384.60
10/28/2016Geoffrey GuyInsiderSell31,682GBX 790£250,287.80
10/27/2016Geoffrey GuyInsiderSell138,318GBX 804£1,112,076.72
10/26/2016Geoffrey GuyInsiderSell130,000GBX 808£1,050,400
10/25/2016Geoffrey GuyInsiderSell125,000GBX 809£1,011,250
10/24/2016Geoffrey GuyInsiderSell68,900GBX 824£567,736
5/11/2016Guy,GeoffreyInsiderSell300,000GBX 444£1,332,000
5/10/2016Lynch ,TomInsiderSell50,000GBX 441£220,500
3/31/2016Wright,StephenInsiderSell58,200GBX 435£253,170
12/18/2015Guy,GeoffreyInsiderSell6,000GBX 366£21,960
12/10/2015Lynch ,TomInsiderSell4,270GBX 451£19,257.70
6/12/2015James NobleInsiderSell20,000GBX 636£127,200
6/11/2015Stephen WrightInsiderSell170,400GBX 641£1,092,264
2/9/2015Christopher John ToveyInsiderSell10,000GBX 404.20£40,420
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for GW Pharmaceuticals plc (LON:GWP)
Latest Headlines for GW Pharmaceuticals plc (LON:GWP)
Source:
DateHeadline
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Moleculin Biotech Inc. and GW Pharmaceuticals PLC
finance.yahoo.com - August 31 at 5:06 AM
finance.yahoo.com logoZynerba Pharma’s failed cannabidiol gel trial has upside for rival GW Pharma
finance.yahoo.com - August 15 at 5:41 AM
fool.com logoBetter Buy: Cara Therapeutics Inc. vs. GW Pharmaceuticals plc
www.fool.com - July 30 at 9:27 AM
feeds.benzinga.com logoGW Pharmaceuticals to Report Q3 Financial Results and Host Conference Call on 7 August, 2017
feeds.benzinga.com - July 24 at 4:21 PM
finance.yahoo.com logoMarijuana Stocks on The Rebound in July 2017
finance.yahoo.com - July 12 at 8:02 PM
finance.yahoo.com logoMedical Marijuana Treatments by GW Pharmaceuticals
finance.yahoo.com - June 23 at 3:39 PM
finance.yahoo.com logoGW Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference on 14 June
finance.yahoo.com - June 7 at 5:07 PM
finance.yahoo.com logoCramer's lightning round: These are the most dangerous stocks in the world
finance.yahoo.com - May 31 at 10:35 PM
finance.yahoo.com logoNew England Journal of Medicine Publishes Cannabis Epilepsy Study
finance.yahoo.com - May 25 at 8:03 PM
finance.yahoo.com logoBlog Coverage: Bristol-Myers Squibs Received EMA Validation of Sprycel for the Treatment in Children with Chronic Myelogenous Leukemia
finance.yahoo.com - May 22 at 11:08 AM
finance.yahoo.com logoGW Pharmaceuticals Announces Research & Development Management Appointments
finance.yahoo.com - May 15 at 11:12 AM
reuters.com logoUK Stocks-Factors to watch on May 10 - Reuters
www.reuters.com - May 10 at 10:47 PM
finance.yahoo.com logoGW Pharmaceuticals to Report Q2 Financial Results and Host Conference Call on 9 May, 2017
finance.yahoo.com - May 2 at 4:06 PM
feeds.benzinga.com logoGW Pharmaceuticals to Report Q2 Financial Results and Host Conference Call on 9 May, 2017
feeds.benzinga.com - May 2 at 10:40 AM
finance.yahoo.com logoGW Pharmaceuticals' Risks Could Be Rewarding
finance.yahoo.com - April 28 at 3:34 PM
fool.com logo10 Reasons Your Marijuana Stock Is a Terrible Investment
www.fool.com - February 27 at 6:59 PM
fool.com logoCould Marijuana Be the Next Miracle Drug for Treating Cancer?
www.fool.com - February 20 at 10:53 AM
thestreet.com logoGW Pharmaceuticals Is Set to Benefit as Cannabis Takes on Cancer
www.thestreet.com - February 9 at 6:25 PM
feeds.benzinga.com logoGW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017
feeds.benzinga.com - January 30 at 8:12 AM
fool.com logo3 Big Risks for Marijuana Stocks in 2017
www.fool.com - January 23 at 4:00 PM
seekingalpha.com logoGW Pharma Cannabinoid Pipeline Undervalued By The Market - Seeking Alpha
seekingalpha.com - December 14 at 6:16 PM
fool.com logoThis Marijuana Stock's Sales Are Shrinking: Should We Care?
www.fool.com - December 6 at 10:38 AM
finance.yahoo.com logoGW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
finance.yahoo.com - December 6 at 10:38 AM
finance.yahoo.com logoGW Pharma Impresses Analysts With Phase 3 Trial Data
finance.yahoo.com - December 5 at 11:14 AM
finance.yahoo.com logoGW Pharma (GWPH) Posts Narrower-than-Expected Loss in Q4
finance.yahoo.com - December 5 at 11:14 AM
finance.yahoo.com logoGW Pharmaceuticals Shows Smaller Than Expected Q4 Loss
finance.yahoo.com - December 5 at 11:14 AM
globenewswire.com logoGW Pharmaceuticals plc Announces Epidiolex® (cannabidiol) Data ... - GlobeNewswire (press release)
globenewswire.com - December 1 at 10:44 AM
lse.co.uk logoNotice of Q4 and year-end results - London South East (registration) (blog)
www.lse.co.uk - November 30 at 10:42 PM
fool.com logo3 Healthcare Stocks Investors Have Been Thankful for This Year
www.fool.com - November 29 at 4:53 PM
fool.com logo3 Healthcare Stocks Investors Have Been Thankful for This Year
www.fool.com - November 29 at 4:53 PM
fool.com logoWhy this Marijuana Stock Was a Top Stock So Far in 2016
www.fool.com - November 29 at 4:53 PM
fool.com logoWhy this Marijuana Stock Was a Top Stock So Far in 2016
www.fool.com - November 29 at 4:53 PM
feeds.benzinga.com logoConcerns Over GW Pharma's Epilepsy Drug-On-Drug Interactions Might Be Overblown
feeds.benzinga.com - November 23 at 1:25 PM
finance.yahoo.com logoGW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November
finance.yahoo.com - November 22 at 8:50 AM
seekingalpha.com logoAssociated British Foods: There's A New Cannabis Cultivator In Town
seekingalpha.com - November 9 at 9:37 AM
lse.co.uk logoDirector Stock Trading Plan - London South East (registration) (blog)
www.lse.co.uk - October 29 at 5:08 PM
lse.co.uk logoDirector Stock Trading Plan - Regulatory News, RNS - London ... - London South East (registration) (blog)
www.lse.co.uk - October 7 at 10:20 AM
finance.yahoo.com logoGW Pharma Attains 52-Week High on Positive Epidiolex Data
finance.yahoo.com - September 27 at 9:57 AM
rttnews.com logoGW Reports Positive Phase 3 Pivotal Trial For Epidiolex In Treatment Of LGS
www.rttnews.com - September 26 at 10:00 AM
feeds.benzinga.com logoGW Pharma's Epidiolex Hits Phase 3 Primary Endpoint For Treating Lennox-Gastaut Syndrome
feeds.benzinga.com - September 26 at 8:27 AM
reuters.com logoExclusive: Vanda Pharmaceuticals prepares to explore a sale - sources
www.reuters.com - September 22 at 5:26 PM
finance.yahoo.com logoWill GW Pharmaceuticals (GWPH) Continue to Surge Higher?
finance.yahoo.com - September 14 at 5:26 PM

Social

Social activity is not available for this stock.

Chart

GW Pharmaceuticals plc (GWP) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff